Get the day's biggest stories sent direct to your inbox so you never miss a thing Researchers in Manchester are leading the first clinical trial to test whether aspirin can help treat an aggressive form of breast cancer.
The cheap and widely-available drug is being trialled as part of a potential new treatment. Researchers hope aspirin could work well when combined with immunotherapy for patients with triple negative breast cancer.
The trial, funded by the Breast Cancer Now Catalyst Programme, which aims to speed up progress in research through innovation and collaboration, is the first clinical study to test if aspirin can make tumours more sensitive to immunotherapy in patients.
Read more on manchestereveningnews.co.uk